AstraZeneca lung cancer drug delays disease by more than a year
April 17, 2015 at 03:00 AM EDT
LONDON, April 17 (Reuters) - An experimental lung cancer pill from AstraZeneca delays disease progression by more than a year, according to new data presented at a medical meeting on Friday.
